» Articles » PMID: 38259

Intracellular PH Changes During the Cell Cycle in Tetrahymena

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 1979 Jul 1
PMID 38259
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The equilibrium distribution of 5,5-dimethyloxazoladine 2,4-dione (DMO) between intra- and extracellular volume was used to estimate intracellular pH (pHi) in Tetrahymena pyiformis. In control experiments, DMO was found to equilibrate rapidly in response to a pH gradient. Under normal growth conditions, pHi was constant over a finite range of external pH, being maintained near pH 7.1 over the external pH range 5.2 to 7.3. This same range of external pH was also optimal for growth. pHi was monitored during the cell cycle of a synchronous population of T. pyriformis GL. The cells were synchronized either by starvation/refeeding or heat shock. Under both conditions, there were two alkaline shifts of approximately 0.4 pH units per cell cycle. These shifts in pH retained a constant remporal relationship to S phase and were not affected by changes in the time, duration, or magnitude of cytokinesis.

Citing Articles

Single-cell intracellular pH dynamics regulate the cell cycle by timing the G1 exit and G2 transition.

Spear J, White K J Cell Sci. 2023; 136(10).

PMID: 37133398 PMC: 10281514. DOI: 10.1242/jcs.260458.


Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches.

Carvalho T, Di Molfetta D, Greco M, Koltai T, Alfarouk K, Reshkin S Cancers (Basel). 2021; 13(23).

PMID: 34885243 PMC: 8657427. DOI: 10.3390/cancers13236135.


The acidic microenvironment as a possible niche of dormant tumor cells.

Peppicelli S, Andreucci E, Ruzzolini J, Laurenzana A, Margheri F, Fibbi G Cell Mol Life Sci. 2017; 74(15):2761-2771.

PMID: 28331999 PMC: 11107711. DOI: 10.1007/s00018-017-2496-y.


Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.

Avnet S, Lemma S, Cortini M, Pellegrini P, Perut F, Zini N Oncotarget. 2016; 7(39):63408-63423.

PMID: 27566564 PMC: 5325373. DOI: 10.18632/oncotarget.11503.


Targeting ion transport in cancer.

Oosterwijk E, Gillies R Philos Trans R Soc Lond B Biol Sci. 2014; 369(1638):20130107.

PMID: 24493755 PMC: 3917361. DOI: 10.1098/rstb.2013.0107.